NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) Cap table
Cap table
Built by 6ix from NeuroSense Therapeutics Ltd.’s releases · as of Apr 28, 2026
- Common shares
- 1,896,902
- Fully diluted
- 1,896,902
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 1,896,902 |
Warrants and options
| Lot |
|---|
| Warrants · US$1.25 · expire about Dec 2029 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 1,896,902 |